Virtus LifeSci Biotech Products ETF
14 hedge funds and large institutions have $10.7M invested in Virtus LifeSci Biotech Products ETF in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.96% more ownership
Funds ownership: 40.01% → 40.97% (+0.96%)
Holders
14
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$300K | |
| 2 | +$95K | |
| 3 | +$19.8K | |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
+$9.96K |
| 5 |
PFS
Prospera Financial Services
Dallas,
Texas
|
+$5K |
Top Sellers
| 1 | -$104K | |
| 2 | -$41K | |
| 3 | -$29.3K | |
| 4 |
LPL Financial
San Diego,
California
|
-$16.1K |